- Home
- DYAI vs ABVC Comparison
DYAI vs ABVC Comparison
Compare DYAI & ABVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DYAI | ABVC |
|---|---|---|
| Founded | 1979 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.5M | 34.6M |
| IPO Year | 2003 | 2009 |
Fundamental Metrics
Financial Performance| Metric | DYAI | ABVC |
|---|---|---|
| Price | $0.69 | $0.80 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 162.2K | 100.0K |
| Earning Date | 05-13-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.14 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,090,345.00 | $509,589.00 |
| Revenue This Year | $122.79 | N/A |
| Revenue Next Year | $100.00 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.65 | $0.82 |
| 52 Week High | $1.60 | $3.39 |
Technical Indicators
Market Signals| Indicator | DYAI | ABVC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 36.55 |
| Support Level | N/A | N/A |
| Resistance Level | N/A | $1.14 |
| Average True Range (ATR) | 0.00 | 0.08 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 0.00 | 19.05 |
Price Performance
Historical ComparisonAbout DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
About ABVC ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.